Pyoderma Gangrenosum

Pyoderma Gangrenosum General Information

The clinical phrase “Pyoderma Gangrenosum” defines one of the many causes that may lead to the development of a certain form of skin ulceration. However, this is not a common cause of this medical disorder. The presence of the skin ulceration may be present at any part of the patient’s skin. However, the most common locations for the development of this medical disorder remain the patient’s lower legs. Some medical scientists consider this medical disorder an auto-immune medical condition. Although this clinical illness can affect patients of any age, studies have shown that most of the patients who are suffering from this medical condition are over 50 years of age. Studies have shown that the presence of this medical disorder is equally common among male patients and female patients.

This clinical condition (commonly known as Pyoderma Gangrenosum) is known to generally affect a patient who presents an underlying internal medical disorder. The most common diseases that make one prone to developing this clinical illness include the following conditions: Chron’s disease, ulcerative colitis and / or any other bowel inflammatory medical disorders, myeloid blood dyscrasias, Wegener granulomatosis , rheumatoid arthritis, PAPA syndrome, chronic active hepatitis,  and so on. However, studies have shown to half of the patients who are suffering from this medical disorder do not present any of the underlying conditions that we have listed here. For this reason, scientists still doubt that there is any direct connection between the presence of a similar risk factor (such as the medical disorders that we have listed above) and the developing of this medical disorder. If you have further questions regarding specific general information about this disorder, please contact a specialized health care provider.

Pyoderma Gangrenosum Symptoms

After studying several patients who have been diagnosed with the presence of this medical condition (Pyoderma Gangrenosum, scientists have composed a list of the most common clinical features of this clinical illness. Most individuals start developing the unpleasant symptoms of this medical disorder in a quite sudden way. The symptoms of this disease generally appear at the site of a certain injury (even a small, minor wound). The early symptoms of this clinical disorder generally develop as blood-blisters, red bumps, small pustules, and so on. After the affected skin has broken down, an ulcer develops. This type of lesion is known to be able to widen and deepen with great rapidity. A characteristic feature of this type of skin lesion is the presence of a purple edge of the ulcer. As it enlarges, the edge becomes undermined. This type of lesion (that may be caused by Pyoderma Gangrenosum) is known to generally trigger severe pain. The patient may develop more than one lesion of this kind at the same time.

If the patient does not receive an adequate therapy for his or her medical condition, his or her lesions (ulcers) will worsen in time. They will probably enlarge, too. However, in some cases the lesions stop changing and they slowly heal. The deepest ulcers (lesions) are known to leave a scar after they heal. The remaining scar is known to generally present a criss-cross pattern. Other patients describe it as cribiform. In some cases, the presence of a rare variant of this disorder, the bullous form of this disease, is known to completely heal without leaving a permanent mark (scar). These are not all the physical features of Pyoderma Gangrenosum. If you are in need of further information, you should seek professional clinical assistance.

Pyoderma Gangrenosum Treatment

The most common therapy options are able to successfully stop the worsening of the lesions; however, complete disappearing of the symptoms only arises after a couple of months of continuous therapy. The length of the treatment trial for the patient’s Pyoderma Gangrenosum may increase if the individual is suffering from an underlying venous medical disorder (which is another common cause for the development of leg ulcers). The diagnosis of this medical condition (commonly referred to as Pyoderma Gangrenosum) is generally set based on the characteristic physical features of this disorder (the appearance of the patient’s lesions). No specific medical evaluations are required in the proper diagnosis of this medical condition. However, the patient may have to submit biopsies of his or her lesions, in order for his or her personal health care provider to rule out any other causes for his ulcerative condition and to see if the patient presents any adjacent infectious diseases.

Blood tests do not generally provide any advantage in diagnosing this clinical disorder. However, in the case of some individuals who have been diagnosed with this illness, blood exams have shown positive results for ANCA (a common abbreviation for the antineutrophil cytoplasmic antibodies). If it has been settled that the patient is indeed suffering from this medical disorder (Pyoderma Gangrenosum), he or she should be immediately granted the professional medical attention of a well trained dermatologist. Most patients are recommended non-surgical therapy options. However, the individual’s necrotic tissue should be carefully removed. A wide surgical debridement of the lesion may determine severe consequences (ulcerative enlargement). In some cases, before the final diagnosis for Pyoderma Gangrenosum is set, the physician recommends patients to start the intake of conventional antibiotic medical products (like Flucoxacillin). If the patient also presents a bacterial infection of his or her lesions, he or she may have to continue their therapy with antibiotic remedies. The same for patients who present hot, red, painful skin (cellulitis).

The most common medicines that are employed in the therapy of the small ulcerative lesions include: steroid medicines, hydrocolloids, Sulfadiazine creams, anti-inflammatory medicines (like Minocycline, Dapsone, and so on), solutions of potassium iodide, and so on. The more severe forms of Pyoderma Gangrenosum require therapies with immunosuppressive remedies. They include: Tacrolimus ointment (it is able to ease the patient’s symptoms by inhibiting calcineurin), oral form of steroids (however, the patient should be extra careful, as such a therapy is known to trigger severe side effects), Methotrexate, Ciclosporin, Mycophenolate mofetil, Cyclophosphamide, and so on. The regular intake of some biological agents (foe example, Infliximab) has also proven to be an effective remedy against this medical disorder.